Central China Normal University

Central China Normal University has been granted 25 US utility patents between 2015 and 2025, placing Central China Normal University at rank #11,972 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.2 claims per patent with primary concentration in G09B (EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS). As a Foreign Corporation, Central China Normal University is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 42.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 4 in the 2015–2019 window, a +425% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Central China Normal University's 8.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Central China Normal University against peers pursuing similar technology classes.